Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-1503 cream in infants and toddlers with atopic dermatitis
CTR20251433Phase 3Active
- Sponsor
- Zedman Pharma
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TAP-1503 in atopic dermatitis (AD), sponsored by Zedman Pharma. Started Aug 2025; status: active.
02
Drugs
TAP-1503
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20251433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251433.